GLAUKOS Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $507.4M | $383.5M | $314.7M | $282.9M | $294.0M |
| Cost of revenue | $111.8M | $94.0M | $75.6M | $69.0M | $66.6M |
| Gross profit | $282.8M | $289.5M | $239.1M | $213.9M | $227.4M |
| Selling, general & administrative | $331.7M | $261.2M | $224.1M | $192.9M | $179.3M |
| Research and development | $150.6M | $136.4M | $138.8M | $123.3M | $101.0M |
| Operating expenses | $482.4M | $411.8M | $367.8M | $296.2M | $260.3M |
| Operating income | -$199.6M | -$122.4M | -$128.7M | -$82.3M | -$32.9M |
| Interest expense | $4.6M | $10.0M | $13.6M | $13.7M | $13.4M |
| Pretax income | -$193.0M | -$145.6M | -$133.7M | -$98.4M | -$49.3M |
| Income tax expense | -$5.4M | $771,000 | $934,000 | $766,000 | $326,000 |
| Net income | -$187.7M | -$146.4M | -$134.7M | -$99.2M | -$49.6M |
| Balance Sheet | |||||
| Cash and equivalents | $90.8M | $169.6M | $93.5M | $119.5M | $100.7M |
| Current assets | $475.0M | $449.8M | $395.5M | $443.9M | $486.1M |
| Total assets | $893.5M | $974.8M | $940.4M | $1.0B | $1.0B |
| Current liabilities | $101.3M | $75.1M | $74.0M | $72.4M | $63.4M |
| Total liabilities | $237.3M | $207.8M | $478.6M | $472.4M | $462.5M |
| Stockholders' equity | $656.2M | $766.9M | $461.8M | $530.0M | $587.2M |
| Cash Flow Statement | |||||
| Cash from operations | -$14.8M | -$61.3M | -$57.8M | -$33.1M | $24.7M |
| Depreciation and amortization | $38.1M | $35.6M | $33.7M | $31.6M | $29.7M |
| Stock-based compensation | $63.2M | $50.2M | $43.5M | $38.6M | $30.1M |
| Capital expenditure | $7.7M | $6.3M | $20.2M | $30.3M | $47.8M |
| Free cash flow | -$22.5M | -$67.6M | -$78.0M | -$63.3M | -$23.1M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 58.7M · Free float 83.3%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.